EUVIMEDEUVIMED entdecken
Open Access

Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma

James S Lewis iD, Saskia Naegele, Vasileios Efthymiou, Mitra Mehrad iD, Kim A Ely, Tim Waterboer, Krystle A Lang Kuhs, Seth J Davis, Kelsey Richard iD, Dipon Das, Daniel L Faden iD

American Journal of Clinical Pathology · 03.06.2024 · 161 (6) · 570-578

DOI: 10.1093/ajcp/aqad185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, online erschienen am 13.02.2024. Verfasst von James S Lewis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology and Vanderbilt University Medical Center, Nashville, TN, US. Hauptthemen laut MEDLINE: Feasibility Studies, Papillomavirus Infections, Oropharyngeal Neoplasms, DNA, Viral. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In this feasibility study, we explored the combined use of circulating tumor human papillomavirus (HPV) DNA (ctHPVDNA) and HPV serology as diagnostic tests for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC).

Methods

Among patients with research-banked serum or plasma at diagnosis, IgG antibodies to oncoproteins from HPV types 16, 18, 31, 33, 35, 45, 52, and 58 were detected with multiplex serology. Positivity for HPV 16 was defined based on detection of combinations of anti-E6, E1, E2, and E7 and for other high-risk types on detection of anti-E6 and anti-E7. Circulating tumor HPV DNA was detected by custom digital droplet polymerase chain reaction (ddPCR) assays for HPV types 16, 18, 33, 35, and 45. p16 immunohistochemistry and high-risk HPV RNA in situ hybridization (ISH) using a cocktail of 18 high-risk HPV types were performed on tissue.

Results

Of 75 patients, 67 (89.3%) were HPV-associated (p16 and HPV RNA ISH positive) and 8 (10.7%) were HPV-independent. All 8 HPV-independent patients were seronegative and negative for ctHPVDNA (100% specificity). Serology was positive in 53 (79.1%) of 67 HPV-associated patients, while ddPCR was positive for ctHPVDNA in 59 (88.6%) of 67 HPV-associated patients. Requiring both tests to be positive resulted in a sensitivity of 50 (74.6%) of 67 while combining assays (either positive) improved sensitivity to 62 (92.6%) of 67.

Conclusions

Compared to HPV RNA ISH, HPV serology and ctHPVDNA are sensitive and highly specific biomarkers for HPV-associated OPSCC at the time of presentation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesPapillomavirus InfectionsOropharyngeal NeoplasmsDNA, ViralHumansFemaleMaleMiddle AgedLiquid BiopsyAgedSquamous Cell Carcinoma of Head and NeckAdultPapillomaviridaeCarcinoma, Squamous CellAged, 80 and overIn Situ HybridizationSensitivity and Specificity

Stichwörter der Autor:innen

circulating tumor DNAhuman papillomavirusoropharyngeal squamous cell carcinomap16serology

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Department of Pathology, Microbiology, and Immunology and Vanderbilt University Medical Center, Nashville, TN, US.
  • Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, US.
  • Mass Eye and Ear, Boston, MA, US.
  • Division of Infections and Cancer Epidemiology, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Department of Epidemiology and Environmental Health, College of Public Health and.
  • Markey Cancer Center, University of Kentucky, Lexington, KY, US.

ORCID-Profile: James S Lewis, Mitra Mehrad, Kelsey Richard, Daniel L Faden

Förderung

  • NIDCR NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • Shared Instrumentation
  • Vanderbilt Tissue Pathology Shared Resource
  • Department of Defense
  • Leica Bond RX
  • National Institutes of Health

Zitieren

APA

Lewis, J. S., Naegele, S., Efthymiou, V., Mehrad, M., Ely, K. A., Waterboer, T., Lang Kuhs, K. A., Davis, S. J., Richard, K., Das, D., & Faden, D. L. (2024). Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma. American Journal of Clinical Pathology, 161(6), 570-578. https://doi.org/10.1093/ajcp/aqad185

Vancouver

Lewis JS, Naegele S, Efthymiou V, Mehrad M, Ely KA, Waterboer T, et al. Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma. American Journal of Clinical Pathology. 2024;161(6):570-578. doi:10.1093/ajcp/aqad185

BibTeX
@article{Lewis2024,
  author = {Lewis, James S and Naegele, Saskia and Efthymiou, Vasileios and Mehrad, Mitra and Ely, Kim A and Waterboer, Tim and Lang Kuhs, Krystle A and Davis, Seth J and Richard, Kelsey and Das, Dipon and Faden, Daniel L},
  title = {Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma},
  journal = {American Journal of Clinical Pathology},
  year = {2024},
  volume = {161},
  number = {6},
  pages = {570--578},
  doi = {10.1093/ajcp/aqad185}
}
Kostenlos starten →